Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept
Journal
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Journal Volume
6
Journal Issue
3
Date Issued
2017
Author(s)
Abstract
To investigate the short-term efficacy and safety of intravitreal aflibercept in a case series of patients with diabetic macular edema (DME) refractory to ranibizumab or bevacizumab.
Subjects
aflibercept; bevacizumab; diabetic macular edema; intravitreal injection; ranibizumab
Type
journal article